Frelii

FRLI · OTC

$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About FRLI

Frélii, Inc. provides consumer affordable access to personalized health assessments and nutrition plans based on genetic data, physiology, environmental and lifestyle factors, and lab diagnostics all on one convenient web platform. The company is headquartered in Lehi, Utah. The company went IPO on 2005-01-18. The firm provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies users’ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Company’s site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The firm provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. The company provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.

Employees
0
Headquarters
Lehi, Utah
Listed
Jan 18, 2005
Sector
Health Care
Industry
Health Care Technology

Leadership

Frelii executives
NameTitleSince
Ian Jenkins—2017
Sandeep Uppal——
Hans Jenkins——
Leslie Norris—2018

Similar companies

Companies in the same industry as Frelii

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.